Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model

The research and development of a pertussis-combined vaccine using a novel inactivated poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio eradication project and to address the recent resurge in pertussis. In the present study, we compared the immunogenicity a...

Full description

Bibliographic Details
Main Authors: Xiaoyu Wang, Na Gao, Jiana Wen, Jingyan Li, Yan Ma, Mingbo Sun, Jiangli Liang, Li Shi
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/1/47
_version_ 1797489879158882304
author Xiaoyu Wang
Na Gao
Jiana Wen
Jingyan Li
Yan Ma
Mingbo Sun
Jiangli Liang
Li Shi
author_facet Xiaoyu Wang
Na Gao
Jiana Wen
Jingyan Li
Yan Ma
Mingbo Sun
Jiangli Liang
Li Shi
author_sort Xiaoyu Wang
collection DOAJ
description The research and development of a pertussis-combined vaccine using a novel inactivated poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio eradication project and to address the recent resurge in pertussis. In the present study, we compared the immunogenicity and efficacy of a candidate DTacP-sIPV with those of a commercial DTacP-wIPV/Hib, DTaP/Hib, pertussis vaccine, and aluminum hydroxide adjuvant control in the rhesus macaque model with a 0-, 1-, and 2-month immunization schedule. At day 28 after the third dose, rhesus macaques were challenged with aerosol pertussis and the antibody and cellular response together with pertussis clinical symptoms were determined. The production of anti-PT, anti-PRN, anti-FHA, anti-DT, anti-TT, and polio type I, II, III antibodies was induced by the candidate DTacP-sIPV, which was as potent as commercial vaccines. In comparison with the control group that showed typical pertussis symptoms of humans after the aerosol challenge, the DTacP-sIPV group did not exhibit obvious clinical pertussis symptoms and had higher neutralization titers of anti-PT, anti-PRN, and anti-FHA. In conclusion, the DTacP-sIPV vaccine was able to induce immunity in rhesus macaques to prevent pertussis infections after immunization. The developed vaccine was as efficient as other commercial vaccines.
first_indexed 2024-03-10T00:23:54Z
format Article
id doaj.art-8a382a0b068841ce805b87f384b4fbdd
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T00:23:54Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-8a382a0b068841ce805b87f384b4fbdd2023-11-23T15:38:28ZengMDPI AGVaccines2076-393X2021-12-011014710.3390/vaccines10010047Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque ModelXiaoyu Wang0Na Gao1Jiana Wen2Jingyan Li3Yan Ma4Mingbo Sun5Jiangli Liang6Li Shi7Laboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaKey Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaKey Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Vaccine Development, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaKey Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaLaboratory of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, ChinaThe research and development of a pertussis-combined vaccine using a novel inactivated poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio eradication project and to address the recent resurge in pertussis. In the present study, we compared the immunogenicity and efficacy of a candidate DTacP-sIPV with those of a commercial DTacP-wIPV/Hib, DTaP/Hib, pertussis vaccine, and aluminum hydroxide adjuvant control in the rhesus macaque model with a 0-, 1-, and 2-month immunization schedule. At day 28 after the third dose, rhesus macaques were challenged with aerosol pertussis and the antibody and cellular response together with pertussis clinical symptoms were determined. The production of anti-PT, anti-PRN, anti-FHA, anti-DT, anti-TT, and polio type I, II, III antibodies was induced by the candidate DTacP-sIPV, which was as potent as commercial vaccines. In comparison with the control group that showed typical pertussis symptoms of humans after the aerosol challenge, the DTacP-sIPV group did not exhibit obvious clinical pertussis symptoms and had higher neutralization titers of anti-PT, anti-PRN, and anti-FHA. In conclusion, the DTacP-sIPV vaccine was able to induce immunity in rhesus macaques to prevent pertussis infections after immunization. The developed vaccine was as efficient as other commercial vaccines.https://www.mdpi.com/2076-393X/10/1/47DTacP-sIPV candidate vaccineimmunogenicityefficacyrhesus macaque model
spellingShingle Xiaoyu Wang
Na Gao
Jiana Wen
Jingyan Li
Yan Ma
Mingbo Sun
Jiangli Liang
Li Shi
Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
Vaccines
DTacP-sIPV candidate vaccine
immunogenicity
efficacy
rhesus macaque model
title Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
title_full Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
title_fullStr Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
title_full_unstemmed Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
title_short Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
title_sort immunogenicity of a candidate dtacp sipv combined vaccine and its protection efficacy against pertussis in a rhesus macaque model
topic DTacP-sIPV candidate vaccine
immunogenicity
efficacy
rhesus macaque model
url https://www.mdpi.com/2076-393X/10/1/47
work_keys_str_mv AT xiaoyuwang immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel
AT nagao immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel
AT jianawen immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel
AT jingyanli immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel
AT yanma immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel
AT mingbosun immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel
AT jiangliliang immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel
AT lishi immunogenicityofacandidatedtacpsipvcombinedvaccineanditsprotectionefficacyagainstpertussisinarhesusmacaquemodel